| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74e75235a5e23300f4696228d54ce80f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c3899a93c972ce60b070fca823112248
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a25c57ed75e8d128d413c84992c4a929
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4d77401386af1ad03c435f474740c19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9cf5808507eb5d556c1490e1cb676792 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-64 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4418 |
| filingDate |
1998-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dac3915f465b5e9c618df74e158c0c2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eab41dd3f81fa4ac06d809c7c5757de2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_890edc1ce88bf8fd7663084a11bca8dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06878902e833b27899817472ff2205ec |
| publicationDate |
1999-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9914194-A1 |
| titleOfInvention |
2,3,5-trisubstituted pyridines as inhibitors of cyclooxygenase-2 |
| abstract |
The invention encompasses the novel compound of Formula (I) as well as a method of treating cyclooxygenase-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula (I). The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula (I). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8946432-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7166618-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6649629-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6825185-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8541471-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112694497-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7790738-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022195579-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9504680-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6525053-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6833373-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7432285-B2 |
| priorityDate |
1997-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |